Quinagolide
Title: Quinagolide
CAS Registry Number: 87056-78-8
CAS Name: (3R,4aR,10aS)-rel-N,N-Diethyl-N¢-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propylbenzo[g]quinolin-3-yl)sulfamide
Additional Names: (±)-1-n-propyl-3a-diethylsulfamoylamino-6-hydroxy-1,2,3,4,4aa,5,10,10ab-octahydrobenzo[g]quinoline
Molecular Formula: C20H33N3O3S
Molecular Weight: 395.56
Percent Composition: C 60.73%, H 8.41%, N 10.62%, O 12.13%, S 8.11%
Literature References: Nonergot dopamine D2-receptor agonist. Prepn: R. Nordmann, T. J. Petcher, EP 77754; eidem, US 4565818 (1983, 1986 both to Sandoz); eidem, J. Med. Chem. 28, 367 (1985). Receptor binding study in vivo: A. Closse et al., Brain Res. 440, 123 (1988). Clinical pharmacology: R. C. Gaillard, J. Brownell, Life Sci. 43, 1355 (1988). Clinical evaluation in hyperprolactinemia: C. Rasmussen et al., Acta Endocrinol. 125, 170 (1991).
Properties: Beige powder, mp 122.5-124°.
Melting point: mp 122.5-124°
 
Derivative Type: Hydrochloride
CAS Registry Number: 94424-50-7
Manufacturers' Codes: CV-205-502; SDZ-205-502
Trademarks: Norprolac (Novartis)
Molecular Formula: C20H33N3O3S.HCl
Molecular Weight: 432.02
Percent Composition: C 55.60%, H 7.93%, N 9.73%, O 11.11%, S 7.42%, Cl 8.21%
Properties: Crystals from methylene chloride + methanol, mp 234-236°.
Melting point: mp 234-236°
 
Therap-Cat: Prolactin inhibitor.
Keywords: Dopamine Receptor Agonist; Prolactin Inhibitor.

Others monographs:
NovobiocinCoptisineMercuric Sodium p-PhenolsulfonatePotassium Triiodomercurate(II) Solution
MonotropeinPhenyltrimethylammonium IodideAcibenzolar-S-methylTacryl®
BromodiphenhydramineTralkoxydimHetacillinManganese Dioxide
Azure BPoiDiploicin3-Quinuclidinol
©2016 DrugLead US FDA&EMEA